180 Life Sciences ATNF Stock
180 Life Sciences Price Chart
180 Life Sciences ATNF Financial and Trading Overview
| 180 Life Sciences stock price | 0.9 USD |
| Previous Close | 0.58 USD |
| Open | 0.58 USD |
| Bid | 0 USD x 900 |
| Ask | 0 USD x 1000 |
| Day's Range | 0.54 - 0.6 USD |
| 52 Week Range | 0.51 - 18 USD |
| Volume | 58.09K USD |
| Avg. Volume | 327.33K USD |
| Market Cap | 3.47M USD |
| Beta (5Y Monthly) | 0.553596 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -15.49 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
ATNF Valuation Measures
| Enterprise Value | 1.69M USD |
| Trailing P/E | N/A |
| Forward P/E | -1.2595652 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.458749 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -0.093 |
Trading Information
180 Life Sciences Stock Price History
| Beta (5Y Monthly) | 0.553596 |
| 52-Week Change | N/A |
| S&P500 52-Week Change | N/A |
| 52 Week High | 18 USD |
| 52 Week Low | 0.51 USD |
| 50-Day Moving Average | 0.68 USD |
| 200-Day Moving Average | 1.69 USD |
ATNF Share Statistics
| Avg. Volume (3 month) | 327.33K USD |
| Avg. Daily Volume (10-Days) | 52.85K USD |
| Shares Outstanding | 5.98M |
| Float | 4.87M |
| Short Ratio | 0.61 |
| % Held by Insiders | 7.40% |
| % Held by Institutions | 4.15% |
| Shares Short | 101.21K |
| Short % of Float | 1.76% |
| Short % of Shares Outstanding | 1.69% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | June 30, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -33.90% |
| Return on Equity (ttm) | -208.74% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -18085968 USD |
| Net Income Avi to Common (ttm) | -51671504 USD |
| Diluted EPS (ttm) | -23.55 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 2.01M USD |
| Total Cash Per Share (mrq) | 0.38 USD |
| Total Debt (mrq) | 614.53K USD |
| Total Debt/Equity (mrq) | 9.15 USD |
| Current Ratio (mrq) | 0.687 |
| Book Value Per Share (mrq) | 1.263 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -13509855 USD |
| Levered Free Cash Flow (ttm) | -9325092 USD |
Profile of 180 Life Sciences
| Country | United States |
| State | CA |
| City | Palo Alto |
| Address | Building 4 |
| ZIP | 94306 |
| Phone | 650 507 0669 |
| Website | https://180lifesciences.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 5 |
180 Life Sciences Corp., a clinical stage biotechnology company, focuses on developing therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. The company product development platforms includes fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which has completed Phase IIb clinical trials that focuses on fibrosis and anti-TNF; Synthetic Cannabidiol (CBD) Analogs platform, which are synthetic pharmaceutical grade molecules close or distant analogs of non-psychoactive cannabinoids, such as CBD for the treatment of inflammatory diseases and pain; and a7nAChR platform, an immune suppressive, which is under preclinical trails that focuses on alpha 7 nicotinic acetylcholine receptor. 180 Life Sciences Corp. is headquartered in Palo Alto, California.
Q&A For 180 Life Sciences Stock
What is a current ATNF stock price?
180 Life Sciences ATNF stock price today per share is 0.9 USD.
How to purchase 180 Life Sciences stock?
You can buy ATNF shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for 180 Life Sciences?
The stock symbol or ticker of 180 Life Sciences is ATNF.
Which industry does the 180 Life Sciences company belong to?
The 180 Life Sciences industry is Biotechnology.
How many shares does 180 Life Sciences have in circulation?
The max supply of 180 Life Sciences shares is 4.38M.
What is 180 Life Sciences Price to Earnings Ratio (PE Ratio)?
180 Life Sciences PE Ratio is now.
What was 180 Life Sciences earnings per share over the trailing 12 months (TTM)?
180 Life Sciences EPS is -15.49 USD over the trailing 12 months.
Which sector does the 180 Life Sciences company belong to?
The 180 Life Sciences sector is Healthcare.
180 Life Sciences ATNF included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16286.45 USD — |
-0.13
|
6.42B USD — | 16181.17 USD — | 16408.51 USD — | — - | 6.42B USD — |
| NASDAQ HealthCare IXHC | 887.09 USD — |
+0.53
|
— — | 878.38 USD — | 889.86 USD — | — - | — — |
- {{ link.label }} {{link}}